Current Oncology Reports

Papers
(The TQCC of Current Oncology Reports is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer165
Surgical Management of Melanoma: Advances and Updates107
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review92
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review78
New Developments in VHL-Associated Neuroendocrine Neoplasms59
NRG1 Fusions: The New Kid on the Block49
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas48
Immunotherapy in Biliary Tract Cancers: Where Are We?48
Brain Prehabilitation for Oncologic Surgery44
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting42
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan40
Surgical Stress and Cancer Progression: New Findings and Future Perspectives39
AXL Inhibitors: Status of Clinical Development38
Current Trends and Challenges of Microbiome Research in Prostate Cancer38
Cellular Therapy in NSCLC: Between Myth and Reality38
The Difficult Airway in Patients with Cancer37
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites36
Head and Neck Mucosal Melanoma: Where Are We Now?36
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients35
The Microbiome in Advanced Melanoma: Where Are We Now?34
An Overview of Angiogenesis in Bladder Cancer31
Appendiceal Neuroendocrine Neoplasms: an Update for 202331
Targeting the PI3K Pathway in Gynecologic Malignancies31
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review30
Proton Therapy in The Treatment of Head And Neck Cancers- Review28
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours28
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations28
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?26
CAR-T Therapies in Solid Tumors: Opportunities and Challenges26
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer25
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations25
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question25
Geographical Disparities in Colorectal Cancer in Canada: A Review24
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews24
Development of Effective Siglec-9 Antibodies Against Cancer23
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma23
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)23
Vascular Inflammation, Cancer, and Cardiovascular Diseases22
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing22
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review22
Surgery for Recurrent Epithelial Ovarian Cancer22
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions22
Current Management of Neuroendocrine Tumour Liver Metastases21
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets21
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials21
Evolving Treatment Approaches to Mucosal Melanoma21
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?21
Management of Peripheral T-cell Lymphomas and the Role of Transplant20
Small Cell and Other Rare Histologic Types of Cervical Cancer20
Current Diagnostic Tools for Breast Cancer-Related Lymphedema20
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging20
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review19
History of Leukemia, Revisited19
Elderly Rectal Cancer: An Updated Review19
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review19
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer19
Current Status on Management of Primary Plasma Cell Leukemia19
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy18
Epidemiology of Cancer in Older Adults: A Systematic Review18
Multimodality Therapies for Localized Prostate Cancer18
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers17
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma17
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights17
Intratumoral Immunotherapy: Is It Ready for Prime Time?17
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review17
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy16
Return to Intended Oncological Therapy: State of the Art and Perspectives16
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development16
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives16
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis16
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions16
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours16
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade16
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?15
Racial Disparities in Breast Cancer: from Detection to Treatment15
Lymphatic Interventions in the Cancer Patient15
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment15
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL15
CDK4/6 inhibitors: The Devil is in the Detail15
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway15
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer15
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas15
CAR T-cell Therapy for Central Nervous System Lymphoma15
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer14
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers14
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab14
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer14
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine14
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science14
Cardio-Oncology in Childhood: State of the Art14
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer14
Advances in Treatment of Waldenström Macroglobulinemia14
Integrative Geriatric Oncology: A Review of Current Practices14
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations14
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism13
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes13
Surviving Burnout as an Oncologist13
0.18636584281921